Influenza Vaccines Market Anticipated to Grow Owing To Alertness of Pandemic Influenza Viruses

Posted on: Nov-2017 | By: 9 Dimen | Medical Devices

Influenza vaccines—also recognized as jabs or shots—are vaccines that guard against influenza. As the influenza virus modifies rapidly, a vaccine’s new version is developed two times a year. Their efficacy differs year to year. It offers a high defense against influenza. Annual vaccination is suggested for all the individuals over 6 Months and also an annual vaccination is recommended for high-risk groups such as the elderly kids between 6 Months and 5 Years, pregnant women, and people with other health issues.

The vaccine is a mix of 3 influenza virus, specifically, influenza type A with H1N1 virus strain, influenza type A with H3N2 virus strain, and influenza type B virus strain. The influenza vaccines market, over the past few years, has seen rapid growth owing to the fear of a looming pandemic. And, the market is also anticipated to grow at a steady rate in the coming period. Also, the havoc caused by the H1N1 virus in the past few years has led to the growth of the market.

Moreover, the growth of the market is also contributed to the rising alertness regarding the pandemic influenza viruses among people and also owing to the involvement of government for the vaccination against influenza viruses. The impelling demands for efficacious and safe influenza vaccine by the organizations that have advanced R&D facilities are also driving the development of new vaccines.

Several people have died in past years owing to the swine flu or H1N1 influenza pandemic across the world. Also, several vaccines are developed to prevent the seasonal and pandemic influenza viruses with the use of recombinant DNA technology and extensive researches are ongoing to produce effective vaccines through the cell culture technology.

Moreover, several non-governmental and governmental organizations are hugely engaged in promoting and monitoring vaccination programs intended at immunizing individuals against the seasonal influenza viruses. Apart from the abovementioned factors, the rising geriatric population and development of age-related and other chronic diseases are contributing to the growth of the Influenza vaccines market.

On the other hand, the strict regulatory structure and being inaccessible to distant areas are few of the factors restricting the growth of the market.